JACOBS LEVY EQUITY MANAGEMENT, INC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 884414 FLORHAM PARK, NJ

Position in APLS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

+$0 QoQ

Shares Held

61,681

+207.5% QoQ

Ownership

0.048%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	256,503	$159,939,880
2	RARE	Ultragenyx Pharmaceutical Inc.	2,939,719	$98,157,217
3	INCY	Incyte Corp	731,774	$82,953,900
4	CORT	Corcept Therapeutics Inc	695,532	$60,476,507
5	HALO	Halozyme Therapeutics, Inc.	322,377	$25,232,447
6	EXEL	Exelixis, Inc.	415,650	$22,615,516
7	AUPH	Aurinia Pharmaceuticals Inc.	1,231,516	$20,898,826
8	ALNY	Alnylam Pharmaceuticals, Inc.	60,986	$18,358,615

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	—	61,681	+207.5%	Shares	Sole	2026-05-15
2024-03-31	—	20,057	+4.7%	Shares	Sole	2024-05-15
2023-12-31	—	19,154	-82.5%	Shares	Sole	2024-02-14
2023-09-30	—	109,508	-64.7%	Shares	Sole	2023-11-17
2021-12-31	—	310,594	-39.5%	Shares	Sole	2022-02-14
2021-09-30	—	513,641	+317.5%	Shares	Sole	2021-11-15
2021-06-30	—	123,025	-52.9%	Shares	Sole	2021-08-16
2021-03-31	—	261,268	+225.0%	Shares	Sole	2021-05-17
2020-12-31	—	80,381	-33.2%	Shares	Sole	2021-02-16
2020-09-30	—	120,243	+51.2%	Shares	Sole	2020-11-16
2020-06-30	—	79,512	—	Shares	Sole	2020-08-17
No filing history on record for this holder in this stock.